Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A minimally invasive system for glucose area under the curve measurement using interstitial fluid extraction technology: evaluation of the accuracy and usefulness with oral glucose tolerance tests in subjects with and without diabetes.

Sakaguchi K, Hirota Y, Hashimoto N, Ogawa W, Sato T, Okada S, Hagino K, Asakura Y, Kikkawa Y, Kojima J, Maekawa Y, Nakajima H.

Diabetes Technol Ther. 2012 Jun;14(6):485-91. doi: 10.1089/dia.2011.0255. Epub 2012 Apr 26.

PMID:
22537393
2.

Evaluation of a minimally invasive system for measuring glucose area under the curve during oral glucose tolerance tests: usefulness of sweat monitoring for precise measurement.

Sakaguchi K, Hirota Y, Hashimoto N, Ogawa W, Hamaguchi T, Matsuo T, Miyagawa J, Namba M, Sato T, Okada S, Tomita K, Matsuhisa M, Kaneto H, Kosugi K, Maegawa H, Nakajima H, Kashiwagi A.

J Diabetes Sci Technol. 2013 May 1;7(3):678-88.

3.

Evaluation of postprandial glucose excursion using a novel minimally invasive glucose area-under-the-curve monitoring system.

Kuranuki S, Sato T, Okada S, Hosoya S, Seko A, Sugihara K, Nakamura T.

J Healthc Eng. 2013;4(4):529-40. doi: 10.1260/2040-2295.4.4.529.

4.

Measurement of glucose area under the curve using minimally invasive interstitial fluid extraction technology: evaluation of glucose monitoring concepts without blood sampling.

Sato T, Okada S, Hagino K, Asakura Y, Kikkawa Y, Kojima J, Watanabe T, Maekawa Y, Isobe K, Koike R, Nakajima H, Asano K.

Diabetes Technol Ther. 2011 Dec;13(12):1194-200. doi: 10.1089/dia.2011.0089. Epub 2011 Jul 19.

PMID:
21770766
5.

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

Metabolism. 2005 Sep;54(9):1168-73.

PMID:
16125528
6.

Usefulness of a novel system for measuring glucose area under the curve while screening for glucose intolerance in outpatients.

Sakamoto K, Kubo F, Yoshiuchi K, Ono A, Sato T, Tomita K, Sakaguchi K, Matsuhisa M, Kaneto H, Maegawa H, Nakajima H, Kashiwagi A, Kosugi K.

J Diabetes Investig. 2013 Nov 27;4(6):552-9. doi: 10.1111/jdi.12096. Epub 2013 May 8.

7.

First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.

Rave K, Sidharta PN, Dingemanse J, Heinemann L, Roggen K.

Diabetes Technol Ther. 2010 Feb;12(2):117-23. doi: 10.1089/dia.2009.0103.

PMID:
20105041
8.

Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.

Fysekidis M, Cosson E, Banu I, Duteil R, Cyrille C, Valensi P.

Metabolism. 2014 Dec;63(12):1553-61. doi: 10.1016/j.metabol.2014.09.006. Epub 2014 Sep 26.

PMID:
25308444
9.

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

Diabetes Care. 2003 Feb;26(2):421-6.

PMID:
12547873
10.

Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring.

Ugi S, Maegawa H, Morino K, Nishio Y, Sato T, Okada S, Kikkawa Y, Watanabe T, Nakajima H, Kashiwagi A.

Diabetes Metab J. 2016 Aug;40(4):326-33. doi: 10.4093/dmj.2016.40.4.326. Epub 2016 Jul 26.

11.

Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes.

Peter R, Dunseath G, Luzio SD, Chudleigh R, Roy Choudhury S, Owens DR.

Diabet Med. 2010 Mar;27(3):266-73. doi: 10.1111/j.1464-5491.2010.02949.x.

PMID:
20536488
12.

[Contribution of post-breakfast plasma glucose to the glycemic control of type 2 diabetic patients].

Sartori MS, Aragon FF, Padovani CR, Pimenta Wde P.

Arq Bras Endocrinol Metabol. 2006 Feb;50(1):53-9. Epub 2006 Apr 17. Portuguese.

13.

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.

Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, Musi N, DeFronzo RA, Cersosimo E.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E846-52. doi: 10.1152/ajpendo.00030.2008. Epub 2008 Mar 11.

15.

Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

Diabetes Care. 2006 Jul;29(7):1613-8.

PMID:
16801587
16.
17.

Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.

Gredal C, Rosenfalck AM, Dejgaard A, Hilsted J.

Scand J Clin Lab Invest. 2007;67(3):327-36.

PMID:
17454847
18.

Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.

Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y.

Diabetes Care. 2003 Apr;26(4):1211-5.

PMID:
12663599
19.

One-hour post-load hyperglycemia by 75g oral glucose tolerance test as a novel risk factor of atherosclerosis.

Tanaka K, Kanazawa I, Yamaguchi T, Sugimoto T.

Endocr J. 2014;61(4):329-34. Epub 2014 Jan 16.

20.

Postprandial hyperglycemia in urban South African blacks with and without coronary artery disease.

Ntyintyane L, Panz V, Raal F, Gill G.

Metab Syndr Relat Disord. 2009 Feb;7(1):23-9. doi: 10.1089/met.2008.0050.

PMID:
19025445

Supplemental Content

Support Center